As for top drugs, Merck's cancer superstar Keytruda is projected to be the world s top-selling drug by a huge margin in 2024, according to the report.
200 countries and territories Merck Co.'s top-selling drugs 2024; Merck Co.'s Keytruda revenue ; Sales forecast of top selling drugs worldwide 2024; The most important statistics.
In head-to-head clinical trial, Chinese firm Akeso's ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck.
Merck's Keytruda rolled to $25 billion in sales in 2024, which likely made it the world's top-selling drug in 2024. (Merck Co.) With Merck
Merck's cancer drug Keytruda is expected to be the top-selling drug globally in 2024, according to data published by Statista.
Merck Co.'s top-selling drugs 2024. Top selling products of Merck Co. based on revenue in 2024 (in million U.S. dollars)
Merck Co.'s top-selling drugs 2024; Merck Co.'s Keytruda revenue ; Sales forecast of top selling drugs worldwide 2024; The most important statistics. GSK's revenue ;
In 2024, Merck's cancer drug Keytruda surpassed the COVID-19 vaccine Comirnaty to become the top-selling pharmaceutical product worldwide
Merck Co.'s top-selling drugs 2024. Top selling products of Merck Co. based on revenue in 2024 (in million U.S. dollars)
Comments